Description

3,5-Dibromo-2-[[[[(3-Methoxy-2-Naphthalenyl)Carbonyl]Amino]Thioxomethyl]Amino]-Benzoic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in research and development pipelines targeting specialized therapeutic areas. It is primarily utilized by pharmaceutical manufacturers and contract research organizations (CROs) engaged in the development of new chemical entities.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of complex drug molecules, especially in oncology and anti-inflammatory research.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Active Pharmaceutical Ingredient (API) Synthesis: A crucial precursor in multi-step synthetic routes for novel APIs.
• Chemical Biology Probes: Can be utilized in the development of molecular probes for studying biological pathways and target validation.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.

Basic Information

Product Name	3,5-Dibromo-2-[[[[(3-Methoxy-2-Naphthalenyl)Carbonyl]Amino]Thioxomethyl]Amino]-Benzoic Acid
CAS No.	532982-10-8
Molecular Formula	C20H13Br2N3O4S
Molecular Weight	551.21 g/mol
Synonyms	2-[(3,5-Dibromobenzoyl)amino]-3-(3-methoxy-2-naphthoyl)thiourea; Benzoic acid, 3,5-dibromo-2-[[[[(3-methoxy-2-naphthalenyl)carbonyl]amino]thioxomethyl]amino]-; 3,5-Dibromo-N-[[(3-methoxy-2-naphthoyl)amino]carbamothioyl]anthranilic acid; 3,5-Dibromo-2-{[(3-methoxy-2-naphthoyl)carbamothioyl]amino}benzoic acid; 532982-10-8; Thiourea, N-(3,5-dibromo-2-carboxyphenyl)-N'-(3-methoxy-2-naphthoyl)-
EINECS	Contact for details

Quality Control

Our production of 3,5-Dibromo-2-[[[[(3-Methoxy-2-Naphthalenyl)Carbonyl]Amino]Thioxomethyl]Amino]-Benzoic Acid adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing all specifications are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This material is light-sensitive (store away from light) and may be hygroscopic (moisture-sensitive). Keep the container tightly sealed under an inert atmosphere if long-term storage is required.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.